Joseph S. Baxter
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Paediatric therapeutic development workshop on osteosarcoma.
Journal: British journal of cancer
Published: April 07, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.
Journal: British journal of cancer
Published: February 04, 2026
Paediatric therapeutic development workshop on medulloblastoma.
Journal: British journal of cancer
Published: December 13, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma.
Journal: Oncogene
Published: June 17, 2024
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.
Journal: Molecular oncology
Published: May 11, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells.
Journal: Cell reports
Published: September 02, 2022
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.
Journal: American journal of human genetics
Published: October 20, 2020
Identifying high-confidence capture Hi-C interactions using CHiCANE.
Journal: Nature protocols
Published: April 20, 2020
Capture Hi-C identifies putative target genes at 33 breast cancer risk loci.
Journal: Nature communications
Published: August 04, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026